Cardiac Rhythm News
Details of the digital format for the Arrhythmia Alliance’s Heart Rhythm Congress 2020(27–30 September) have been released, with the event to be hosted on a purpose-built virtual conference centre.
Researchers at Washington University (St Louis, USA) led by Jennifer N Avari Silva, associate professor of pediatrics at the School of Medicine, and Jonathan Silva, associate professor of biomedical engineering in the McKelvey School of Engineering, co-led a team that tested a Microsoft HoloLens headset with custom software during cardiac ablation procedures on patients at […]
Johnson & Johnson Medical Devices Companies has today announced the launch of Biosense Webster’s Carto 3 system version 7 and the Carto Prime mapping module. This represents the most advanced version of the Carto 3 system, the company’s three-dimensional (3D) heart mapping system. The Carto Prime mapping module adds tools to the Carto 3 platform […]
Corresponding author Valentin Fuster (Mount Sinai Heart, New York, USA) and colleagues report in the Journal of the American College of Cardiology that hospitalised COVID-19 patients treated with anticoagulants had improved outcomes both in and out of the intensive care unit setting.
Same-day discharge after atrial fibrillation (AF) ablation is feasible for the majority of patients when a standardised protocol is used, findings of a multicentre cohort study, published in the Journal of the American College of Cardiology (JACC), suggest.
In response to a recent American College of Cardiology (ACC) review that advocated that troponin should only be measured when a diagnosis of acute myocardial infarction is being considered, Andrew R Chapman (BHF Centre for Cardiovascular Science, Royal Infirmary of Edinburgh, Edinburgh, UK) and colleagues argue in Circulation that high-sensitivity cardiac troponin “could actually be an ally in the […]
The reduced levels of angiotensin converting enzyme (ACE) 2 associated with cardiovascular disease and increasing age lead to a higher susceptibility to greater disease severity in COVID-19.
The US Food and Drug Administration (FDA) has issued an immediately-in-effect guidance that allows manufacturers of certain FDA-cleared non-invasive, vital-sign-measuring devices to expand their use so that health care providers can use them to monitor patients remotely.
Almost 70% of patients treated with a leadless left ventricular (LV) endocardial pacing system had a favourable clinical response at six months, a post-market surveillance registry has shown.Almost 70% of patients treated with a leadless left ventricular (LV) endocardial pacing system had a favourable clinical response at six months, a post-market surveillance registry has shown.
Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device to minimise stroke risk in atrial fibrillation (AF) patients, and Sheba Medical Center (Ramat Gan, Israel), have announced the clinical proof-of-concept data evaluating the safety of LAA closure through Append’s patented tissue manipulation procedure.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!